Literature DB >> 6612234

Presenting symptoms, treatment delay and survival in bladder cancer.

S Mommsen, J Aagaard, A Sell.   

Abstract

In 212 consecutive patients with bladder tumour, relationships between symptoms, demographic factors, delay before treatment and survival rate were investigated. The presenting symptom was haematuria in 79% of the patients. The interval from onset of symptoms until treatment averaged 28 weeks (median = 15 weeks). The general practitioner delay comprised half of the total delay. Patients with cystitis as the presenting symptom and women with haematuria had the longest doctor delay. The length of delay did not influence the crude survival rate in patients with tumours in the two highest TNM stages. In T1 and T2 tumours, shorter delay tended to give a better survival rate.

Entities:  

Mesh:

Year:  1983        PMID: 6612234     DOI: 10.3109/00365598309180162

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  16 in total

1.  Alarm symptoms in primary care.

Authors:  Robin Fox; John Fletcher
Journal:  BMJ       Date:  2007-05-19

2.  Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.

Authors:  David S Han; Weiping Zhou; John D Seigne; Kristine E Lynch; Florian R Schroeck
Journal:  Urology       Date:  2018-08-20       Impact factor: 2.649

3.  Delays in diagnosing and treating bladder cancer.

Authors:  M J Stower
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

4.  The haematuria clinic.

Authors:  P Marazzi; R Gabriel
Journal:  BMJ       Date:  1994-02-05

Review 5.  Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies.

Authors:  Nicholas Summerton; Sara Mann; Alan S Rigby; Julie Ashley; Sarah Palmer; John W Hetherington
Journal:  Br J Gen Pract       Date:  2002-04       Impact factor: 5.386

6.  An analysis of preoperative delays prior to radical cystectomy for bladder cancer in Quebec.

Authors:  Nader Fahmy; Wassim Kassouf; Suganthiny Jeyaganth; Moamen Amin; Salaheddin Mahmud; Jordan Steinberg; Simon Tanguay; Armen Aprikian
Journal:  Can Urol Assoc J       Date:  2008-04       Impact factor: 1.862

7.  Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment.

Authors:  M C Gulliford; A Petruckevitch; P G Burney
Journal:  BMJ       Date:  1991-08-24

Review 8.  Management of macroscopic haematuria in the emergency department.

Authors:  Derek Hicks; Chi-Ying Li
Journal:  Emerg Med J       Date:  2007-06       Impact factor: 2.740

9.  The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice.

Authors:  Rudi Bruyninckx; Frank Buntinx; Bert Aertgeerts; Viviane Van Casteren
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

10.  Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers.

Authors:  U Macleod; E D Mitchell; C Burgess; S Macdonald; A J Ramirez
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.